Pulmonary imaging often identifies suspicious abnormalities resulting in supplementary diagnostic procedures. This study aims to investigate whether the metabolic fingerprint of plasma allows to discriminate between patients with lung inflammation and patients with lung cancer. | The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer